New antibody shows promise against dengue in early trial
Disease control
Completed
This study tested a new drug called AV-1, which is a lab-made antibody, to see if it can prevent or treat dengue virus type 3 infection. Eighty-five healthy adults received either a low, medium, or high dose of AV-1 or a placebo, and were then exposed to a controlled dengue virus…
Phase: PHASE2 • Sponsor: AbViro LLC • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC